Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) had its target price upped by research analysts at JPMorgan Chase & Co. from $206.00 to $212.00 in a report released on Monday,Benzinga reports. The firm presently has an “overweight” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 16.66% from the company’s current price.
MRSH has been the subject of several other reports. Barclays cut their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Cantor Fitzgerald boosted their target price on Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a research report on Thursday. Mizuho raised their price target on Marsh & McLennan Companies from $194.00 to $197.00 and gave the company a “neutral” rating in a report on Thursday. UBS Group lifted their price target on Marsh & McLennan Companies from $203.00 to $212.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Finally, Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $200.81.
Get Our Latest Stock Analysis on MRSH
Marsh & McLennan Companies Price Performance
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business’s revenue was up 7.6% on a year-over-year basis. Sell-side analysts forecast that Marsh & McLennan Companies will post 10.37 EPS for the current year.
Insider Buying and Selling
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.
Institutional Trading of Marsh & McLennan Companies
Several large investors have recently modified their holdings of MRSH. Solstein Capital LLC purchased a new stake in Marsh & McLennan Companies in the 4th quarter valued at approximately $25,000. Asset Dedication LLC purchased a new position in Marsh & McLennan Companies during the first quarter worth $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies in the fourth quarter worth $26,000. KERR FINANCIAL PLANNING Corp purchased a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at $27,000. Finally, Golden State Wealth Management LLC acquired a new stake in shares of Marsh & McLennan Companies during the fourth quarter valued at $27,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- China’s Helium Ban Could Reshape the AI Supply Chain
- Analysts See Major Upside for These 5 Stocks
- AMD’s 5C Deal Positions It as a Direct NVIDIA Rival
- AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
